Tamoxifen therapy for encapsulating peritoneal sclerosis: mechanism of action and update on clinical experiences
Guest, S.
Peritoneal Dialysis International Journal of the International Society for Peritoneal Dialysis 29(3): 252-255
2009
ISSN/ISBN: 0896-8608 PMID: 19458291 Document Number: 636733
Document emailed within 1 workday
Related Documents
Banoth, P.; Khanna, R. 2017: Bleeding Peritoneum During Peritoneal Dialysis: a Case of Early Encapsulating Peritoneal Sclerosis? Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 33(2017): 50-54Matsuoka, T.; Maeda, Y.; Matsuo, K.; Naiki, Y.; Tamai, Y.; Sakaguchi, M.; Hasegawa, H.; Funauchi, M.; Kanamaru, A. 2008: Hepatocyte growth factor prevents peritoneal fibrosis in an animal model of encapsulating peritoneal sclerosis Journal of Nephrology 21(1): 64-73
Honda, K.; Nitta, K.; Horita, S.; Tsukada, M.; Itabashi, M.; Nihei, H.; Akiba, T.; Oda, H. 2003: Histologic criteria for diagnosing encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 19: 169-175
Yamamoto, H.; Nakayama, M.; yamamoto, R.; Otsuka, Y.; Takahashi, H.; Kato, N.; Hayakawa, H.; Hasegawa, T.; Ikeda, M.; Yokoyama, K.; Kawaguchi, Y.; Mukai, H.; Hosoya, T. 2002: Fifteen cases of encapsulating peritoneal sclerosis related to peritoneal dialysis: a single-center experience in Japan Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 18: 135-138
Hendriks, M.P.; de Sévaux, R.G.L.; Hilbrands, L.B. 2008: Encapsulating peritoneal sclerosis in patients on peritoneal dialysis Netherlands Journal of Medicine 66(7): 269-274
Yamamoto, R.; Nakayama, M.; Hasegawa, T.; Miwako, N.; Yamamoto, H.; Yokoyami, K.; Ikeda, M.; Kato, N.; Hayakawa, H.; Takahashi, H.; Otsuka, Y.; Kawaguchi, Y.; Hosoya, T. 2002: High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatment Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 18: 131-134
Durić, P.; Majster, Z.; Popović, V.Stanković.; Radović, V.Maslarević.; Dimković, N. 2013: Encapsulating peritoneal sclerosis--case report Medicinski Pregled 66(3-4): 185-188
Summers, A.M.; Brenchley, P.E.C. 2006: An international encapsulating peritoneal sclerosis registry and DNA bank: why we need one now Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 26(5): 559-563
de Vos Tot Nederveen Cappel, W.H.; Dubbeld, J.; Willems, S.M.; Ringers, J.; van Hoek, B. 2008: Liver transplantation in a patient with encapsulating peritoneal sclerosis Netherlands Journal of Medicine 66(7): 280-282
Wong, C.F.; Beshir, S.; Khalil, A.; Pai, P.; Ahmad, R. 2005: Successful treatment of encapsulating peritoneal sclerosis with azathioprine and prednisolone Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 25(3): 285-287
Nakamoto, H. 2005: Encapsulating peritoneal sclerosis--a clinician's approach to diagnosis and medical treatment Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 25(Suppl 4): S30-S38
Duman, S.; Bozkurt, D.; Sipahi, S.; Sezak, M.; Ozkan, S.; Ertilav, M.; Sen, S.; Ok, E. 2008: Effects of everolimus as an antiproliferative agent on regression of encapsulating peritoneal sclerosis in a rat model Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 24: 104-110
Kawanishi, H.; Ide, K.; Yamashita, M.; Shimomura, M.; Moriishi, M.; Tsuchiya, S.; Dohi, K. 2008: Surgical techniques for prevention of recurrence after total enterolysis in encapsulating peritoneal sclerosis Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 24: 51-55
Limmroth, V.; Waeber, C.; Diener, H.C. 1995: Sumatriptan Update information on pharmacology, mechanism of action and clinical use Aktuelle Neurologie 22(1): 31-39
Huber, M. 1988: Interferon therapy in multiple sclerosis. Mechanism of action, side effects, results Der Nervenarzt 59(9): 514-520
Powles, T.J.; Gordon, C.; Coombes, R.C. 1982: Clinical trial of multiple endocrine therapy for metastatic and locally advanced breast cancer with tamoxifen-aminoglutethimide-danazol compared to tamoxifen used alone Cancer Research 42(8 Suppl): 3458s-3460s
Garosi, G.; Di Paolo, N. 2000: Pathophysiology and morphological clinical correlation in experimental and peritoneal dialysis-induced peritoneal sclerosis Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 16: 204-207
Tiuliandin, S.A.; Zhukov, N.V. 2009: Anti-VEGF therapy: clinical effectiveness, mechanism of antitumor action and resistance Voprosy Onkologii 55(3): 375-381
Fujiyama, J.; Sakakura, C.; Takagi, T.; Itoh, T.; Takemura, M.; Touma, A.; Shimomura, K.; Yunning, H.; Longhai, H.; Tsujimoto, H.; Yamasaki, J.; Otsuji, E.; Hagiwara, A.; Yamagishi, H. 2001: Analysis of the action of dextran sulfate as a prophylaxis for peritoneal cancer metastasis, and its acting mechanism Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(11): 1677-1680
1994: Alpha-lipoic acid in diabetic neuropathy. Action mechanism and therapy. Clinical picture and pathogenesis of diabetic neuropathy Der Internist 35(6 Alpha-Liponsa): 1-4